1. Home
  2. EXP vs KRYS Comparison

EXP vs KRYS Comparison

Compare EXP & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Materials Inc

EXP

Eagle Materials Inc

HOLD

Current Price

$198.03

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$300.60

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXP
KRYS
Founded
1963
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
7.8B
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
EXP
KRYS
Price
$198.03
$300.60
Analyst Decision
Hold
Strong Buy
Analyst Count
9
11
Target Price
$227.11
$297.60
AVG Volume (30 Days)
324.6K
282.1K
Earning Date
05-19-2026
05-04-2026
Dividend Yield
0.49%
N/A
EPS Growth
1.18
128.00
EPS
11.21
1.83
Revenue
$495,023,000.00
$389,130,000.00
Revenue This Year
$1.97
$38.74
Revenue Next Year
$1.95
$32.53
P/E Ratio
$17.76
$164.45
Revenue Growth
N/A
33.94
52 Week Low
$171.99
$123.03
52 Week High
$243.64
$319.48

Technical Indicators

Market Signals
Indicator
EXP
KRYS
Relative Strength Index (RSI) 45.20 59.92
Support Level $171.99 $244.43
Resistance Level $239.91 $319.48
Average True Range (ATR) 7.43 13.31
MACD -1.37 -0.41
Stochastic Oscillator 29.45 75.88

Price Performance

Historical Comparison
EXP
KRYS

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: